PositiveID Corporation
PositiveID Corporation is a life sciences tools and diagnostics company specializing in biological detection and molecular diagnostic systems for homeland security and global healthcare. They develop microfluidic systems for biological threat detection, airborne pathogen detection, rapid diagnostics, and sample preparation. The company also has a leadership in mobile technology vehicle markets and holds a portfolio of patents for biological detection automation.
Industries
Nr. of Employees
small (1-50)
PositiveID Corporation
Products
Autonomous environmental bioagent detector (field-deployable)
A system designed for autonomous air sampling and on-site molecular detection of airborne biological threats intended to meet next-generation environmental biosurveillance requirements.
Handheld real-time PCR point-of-need detection system (prototype)
A portable molecular diagnostic instrument and consumable format designed to perform real-time PCR for rapid detection of multiple pathogens at the point of need.
Autonomous environmental bioagent detector (field-deployable)
A system designed for autonomous air sampling and on-site molecular detection of airborne biological threats intended to meet next-generation environmental biosurveillance requirements.
Handheld real-time PCR point-of-need detection system (prototype)
A portable molecular diagnostic instrument and consumable format designed to perform real-time PCR for rapid detection of multiple pathogens at the point of need.
Services
On-site deployment, field testing and program evaluation of environmental and point-of-need detection systems for government and first-responder use.
Development and prototyping of compact molecular diagnostic assays and instruments targeting human, veterinary and agricultural pathogens.
Integration of diagnostic instruments into mobile/vehicle platforms for rapid response and distributed testing.
On-site deployment, field testing and program evaluation of environmental and point-of-need detection systems for government and first-responder use.
Development and prototyping of compact molecular diagnostic assays and instruments targeting human, veterinary and agricultural pathogens.
Integration of diagnostic instruments into mobile/vehicle platforms for rapid response and distributed testing.
Expertise Areas
- Molecular diagnostics development
- Biosurveillance and biodefense detection systems
- Microfluidic device design and automation
- Point-of-need/portable diagnostics
Key Technologies
- Real-time PCR (qPCR)
- Microfluidics
- Thermal cycler integration
- Automated sample preparation
News & Updates
PositiveID announced the addition of Listeria detection to its FireflyDX onsite detection prototype.
The CSO of PositiveID's subsidiary joined the Cambridge Healthtech Institute’s 26th Biodetection Technologies conference.
The CEO of PositiveID discussed a new distribution agreement with a non-invasive patient monitoring technology company.
PositiveID announced its plans to exhibit a non-contact thermometer at the upcoming conference.
The CSO of PositiveID called for legislation to dismantle North Korea's chemical and biological weapons stockpile.
PositiveID announced the addition of Listeria detection to its FireflyDX onsite detection prototype.
The CSO of PositiveID's subsidiary joined the Cambridge Healthtech Institute’s 26th Biodetection Technologies conference.
The CEO of PositiveID discussed a new distribution agreement with a non-invasive patient monitoring technology company.
PositiveID announced its plans to exhibit a non-contact thermometer at the upcoming conference.
The CSO of PositiveID called for legislation to dismantle North Korea's chemical and biological weapons stockpile.